Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration-Reference-Cited by-同舟云学术

Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration

Published:2021-01-15 Issue:2 Volume:7 Page:e656
ISSN:2373-8731
Container-title:Transplantation Direct
language:en
Short-container-title:

Author:

Lakhani Laila,Alasfar Sami,Bhalla Anshul,Aala Amtul,Rosenberg Avi,Ostrander Darin,Schollenberger Megan D.,Brennan Daniel C.,Lipson Evan J.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference11 articles.

1. Cell-free DNA: an upcoming biomarker in transplantation.;Gielis;Am J Transplant,2015

2. Universal noninvasive detection of solid organ transplant rejection.;Snyder;Proc Natl Acad Sci U S A,2011

3. Cell-free DNA and active rejection in kidney allografts.;Bloom;J Am Soc Nephrol,2017

4. Immune checkpoint inhibitors and the risk of allograft rejection: a comprehensive analysis on an emerging issue.;Aguirre;Oncologist,2019

5. Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report.;Kwatra;J Med Case Rep,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to Late Noninfectious Post-Transplant Complications;Advances in Kidney Disease and Health;2024-09

2. Nivolumab + Tacrolimus + Prednisone ± Ipilimumab for Kidney Transplant Recipients With Advanced Cutaneous Cancers;Journal of Clinical Oncology;2024-03-20

3. Use of immune checkpoint inhibitors in solid organ transplant recipients with advanced cutaneous malignancies;Frontiers in Transplantation;2023-10-30

4. Immune checkpoint blockade for organ-transplant recipients with cancer: A review;European Journal of Cancer;2022-11

5. Systematic review of programmed cell death-1 inhibitor therapy for advanced-stage cutaneous squamous cell carcinoma in solid-organ transplant recipients;Journal of Dermatological Treatment;2022-09-05